Sales of insulin Lantus rose nearly 31 percent, to 518 million euros ($746 million), lifted by the launch of a new disposable pen used to administer the ...
all 2 news articles
... and clinical mood states. robin christensen was the statistical expert/consultant in the lantus medical expert panel for sanofi-aventis (denmark), ...
After sitting in the airtight trunk of my agent's car during the three-hour drive to Tucson, both the insulated bag and the Lantus emerged hot! ...
Controlling blood glucose levels with insulin shots like Sanofi-Aventis' (NYSE: SNY) Lantus or other anti-diabetic compounds like Eli Lilly (NYSE: LLY) and ...
... danish major is facing competition here from sanofi aventis' glargine, lantus, and eli lilly's recently-launched exenatide injection byetta. however, ...
The Danish major is facing competition here from Sanofi Aventis' glargine, Lantus, and Eli Lilly's recently-launched exenatide injection Byetta. ...
... allows good control of the diabetic cat and is "far superior to that from NPH, Humulin insulin, or the newer human products called 'Lantus' (glargine) ...
Less diurnal variation in insulin concentration was observed in subjects administered FT-105 compared with Lantus. FT-105 was well tolerated by subjects, ...
... allows good control of the diabetic cat and is "far superior to that from NPH, Humulin insulin, or the newer human products called 'Lantus' (glargine) ...